NIDDK Central Repository - Satiety testing in diabetic gastroparesis: Effects of insulin pump therapy with continuous glucose monitoring on upper gastrointestinal symptoms and gastric myoelectrical activity.

An official website of the United States government

NIDDK Central Repository

Publication Information

DOI

10.1111/nmo.13720

PubMed ID

31574209

Public Release Type

Journal

Publication Year

2020

Affiliation

National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.

Authors

Abell TL, Calles-Escandon J, Farrugia G, Grover M, Hamilton F, Hasler WL, Koch KL, Lee L, McCallum RW, Miriel L, Nguyen LA, NIDDK Gastroparesis Clinical Research Consortium, Parkman HP, Pasricha PJ, Sarosiek I, Snape WJ, Tonascia J, Van Natta M

Studies

GLUMIT

Citation

Koch KL, Hasler WL, Van Natta M, Calles-Escandon J, Grover M, Pasricha PJ, Snape WJ, Parkman HP, Abell TL, McCallum RW, Nguyen LA, Sarosiek I, Farrugia G, Tonascia J, Lee L, Miriel L, Hamilton F, NIDDK Gastroparesis Clinical Research Consortium. Satiety testing in diabetic gastroparesis: Effects of insulin pump therapy with continuous glucose monitoring on upper gastrointestinal symptoms and gastric myoelectrical activity. Neurogastroenterol Motil 2020 Jan;32(1):e13720. Epub 2019 Oct 1.

Abstract

Symptoms induced by caloric or non-caloric satiety test meals and gastric myoelectrical activity (GMA) have not been studied in patients with diabetic gastroparesis (DGP) before and after intense glucose management.